NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HSBC HOLDINGS PLC | 75,848 | $45,569 | 0.00% |
| Invesco Ltd. | 359,347 | $214,027 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 57,083 | $33,999 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 340 | $187 | 0.00% |
| ProShare Advisors LLC | 12,429 | $7,403 | 0.00% |
| BlackRock Inc. | 7,684,629 | $4,576,965 | 0.00% |
| Bank of New York Mellon Corp | 88,259 | $52,567 | 0.00% |
| MACQUARIE GROUP LTD | 256,385 | $153,000 | 0.00% |
| Citadel Advisors | 8,100 | $4,824 | 0.00% |
| Citadel Advisors | 46,800 | $27,874 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 140,439 | $83,645 | 0.00% |
| HRT FINANCIAL LP | 34,167 | $20 | 0.00% |
| SIMPLEX TRADING, LLC | 10,625 | $6 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 18,163 | $10,818 | 0.00% |
| Princeton Global Asset Management LLC | 100 | $60 | 0.00% |
| IEQ CAPITAL, LLC | 11,594 | $6,905 | 0.00% |
| SIGNATUREFD, LLC | 3,200 | $1,906 | 0.00% |
| Tower Research Capital LLC (TRC) | 22,599 | $13,469 | 0.00% |
| McClarren Financial Advisors, Inc. | 157 | $0 | 0.00% |
| Cutler Group LLC / CA | 2,900 | $1 | 0.00% |
External links
This page lists NEKTAR THERAPEUTICS's shareholders in Q3 2023. To view NEKTAR THERAPEUTICS's shareholder history, click here.